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1. Introduction 
During the last two decades it emerged that cGMP-dependent protein kinases (PKG) act as 
signalling molecules with pleiotropic physiological functions e.g. in the cardiovascular 
system, in the gastrointestinal tract, immune system and central nervous system (Hofmann 
et al., 2006). The cellular effects of PKG are transmitted by its phosphorylated substrates. 
The identification of different PKG substrates in the diverse organs and cells and the 
analysis of the interaction of PKG with its substrates are important issues which are strongly 
targeted by several research groups recently (summarized in (Schlossmann & Desch, 2009)). 
An important step for elucidating the identity and function of cGMP-kinase substrate 
proteins was the use of affinity chromatography methods utilizing immunoprecipitation or 
cyclic nucleotide based affinity columns. Thereby, a ternary complex of cGMP-kinase was 
purified which consists of the PKG1 isoform PKG1ǃ, the inositol-trisphosphate receptor 
type 1 (InsP3R1) and the inositol-trisphosphate receptor-associated cGMP-kinase substrate 
protein (IRAG). Functional analysis by genetic deletion of IRAG in mice revealed that IRAG 
is essential for relaxation of vascular smooth muscle and for inhibition of platelet 
aggregation. Meanwhile, it was elucidated that IRAG also interacts with further isoforms of 
InsP3R, namely InsP3R2 and InsP3R3. Furthermore, the ternary PKG1 core complex 
associates with several other proteins which might tune the cellular function of PKG1 in 
various tissues. In comparison, the association of PKG1ǂ with substrate proteins, MYPT1 or 
RGS2, was also identified by affinity chromatography including immunoprecipitation, GST-
fusion proteins and/or His-tagged proteins. Therefore, the stable interaction of PKG with its 
substrate proteins might be a common theme and might lead to the view that direct 
interactions convert the intracellular function of PKG in analogy to the mechanisms which 
were identified for cAMP-dependent protein kinases. Therefore, affinity chromatography 
methods are essential tools for the identification of PKG substrate proteins and function in 
cells and tissues. The present review will give an overview of the structural and functional 
features of PKGs and of diverse PKG complexes which were identified by different affinity 
chromatographic techniques.  
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2. cGMP-dependent protein kinases (PKG): Structure and function 
PKG are stimulated by cGMP which is a key cellular second messenger. cGMP is 
synthesized by cytosolic soluble guanylyl cyclases (sGC) and membrane-bound particular 
guanylyl cyclases (pGC). sGC are activated by the gaseous molecule nitric oxide (NO). pGC 
are integral membrane proteins which are stimulated by the natriuretic peptides ANP, BNP, 
CNP or guanylin/uroguanylin. The different intracellular locations of these enzymes lead to 
the view that the localized synthesis of cGMP could differentiate the alternate function of 
NO and natriuretic peptides (Castro et al., 2010) 
PKGs are Ser/Thr kinases which phosphorylate its substrates at the recognition site K/R K/R 
X S/T (one letter code of aa; X can be each aa). PKGs are expressed as three different proteins: 
PKG1ǂ with 676 aa, PKG1ǃ with 686 aa, PKG2 with 762 aa. PKG1 and PKG2 are encoded by 
two different genes, prkg1 and prkg2. The PKG1 isoforms are cytosolic enzymes, whereas 
PKG2 is plasma membrane-bound by an N-terminal myristoylation modification. The two 
PKG1 isoforms PKG1ǂ and PKG1ǃ are expressed from the prkg1 gene by differential splicing 
and thereby differ in the N-terminal first ~100 aa which reside isoleucine/leucine zipper 
regions (LZ) (Fig. 1). These LZ exhibit several isoform-specific functions: homodimerization, 
recognition of specific-substrates, intracellular targeting. Furthermore, the Ka for cGMP-
activation of PKG1 isoforms varies more than 10-fold. The Ka (cGMP) of PKG1ǂ is 0.059 µM 
and of PKG1ǃ is 0.79 µM. Recently, the structural features of PKG1 could be more specified by 
the first crystal structures of the N-terminal leucine zipper of PKG1ǃ and the cGMP-binding 
domains of PKG1ǃ (Casteel et al., 2011; Kim et al., 2011). Homodimerization of PKG1ǃ is 
mediated by eight Ile/Leu heptad repeats. Thereby, hydrophilic aa residues are coordinated in 
a “knobs into holes” structure which assists the dimer formation. NMR studies of the PKG1ǂ 
N-terminal domain (aa 1-39) revealed an ǂ-helical structure with a parallel monomeric 
association of the coiled-coil domain which warrants PKG1ǂ homodimerization through fixed 
electrostatic interactions. The inhibitory sequence (IS) contains the substrate-like sequence 
PRT59TR with autophosphorylation site (Thr59) of PKG1ǂ (Aitken et al., 1984) and the 
presumed pseudosubstrate KRQAISAE of PKG1ǃ (Kemp & Pearson, 1990; Ruth et al., 1997). 
The IS inactivates the kinase when cGMP is absent. 
Upon cGMP binding the kinase is activated. The holo-enzymes of PKG1ǂ or PKG1ǃ contain 
two different cyclic nucleotide-binding domains CNBD-A and CNBD-B (Fig. 1). The recently 
obtained cocrystals of PKG1ǃ (aa92-227) containing the N-terminal cyclic nucleotide binding 
domain of PKG1ǃ (CNBD-A) together with cGMP and cAMP revealed new insights into the 
cyclic nucleotide-binding mechanism (Kim et al., 2011). cGMP attachs only in the syn 
conformation to CNBD-A, whereas cAMP in either syn or anti configuration. Surprisingly, 
CNBD-A binds both cGMP and cAMP with high affinity. Only a 2-fold preference was 
found for cGMP. Therefore, a possible cooperative action of CNBD-A and CNBD-B in cyclic-
nucleotide-binding is proposed which should ensure a more differential cyclic nucleotide 
binding profile of PKG1. The recently published crystal structure of the regulatory domain 
containing both cGMP-binding sites of PKG1ǂ (aa78-355) revealed a switch helix which 
promotes the formation of a hydrophobic interface between both cGMP-binding sites 
(Osborne et al., 2011). The regulatory domain is followed by the catalytic domain 
comprising an ATP binding - and a substrate binding domain. The 3-dimensional structure 
of these domains was not reported so far. Therefore, the structural elucidation of these 
different PKG1-domains and the holo-enzyme are still new challenges which will be 
essential for the functional insight of PKG1. 
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(a) 
 
(b) 
(A) The PKG1 is subdivided into the regulatory domain at the N terminus and the catalytic domain at 
the C terminus. The regulatory domain consists of the leucine zipper (LZ), the inhibitory sequence (IS) 
and the two cGMP binding pockets (cGMP-A/B = CNBD-A/B). The LZ is necessary for dimerization 
and docking to the substrates (Casteel et al., 2011). The primary sequences of the N-terminal 45 amino 
acids of the PKG1ǂ LZ and of the N-terminal 50 amino acids of the PKG1ǃ LZ are illustrated. The amino 
acids are grouped in a heptad repeat (a-g). The a-positions exhibit primary leucine or isoleucine 
residues (shaded in lilac) and the d-positions are mostly charged or hydrophilic residues (shaded in 
pink). (B) Scheme of PKG1ǃ regulatory domain structure (Casteel et al., 2011). Leucine Zipper: The ǂ-
helical structure is depicted in green. Side chains in the helix are marked. The linker sequence between 
the leucine zipper and the autoinhibitory domain is variable between PKG1ǂ and PKG1ǃ, but is not 
important for the PKG1ǂ or PKG1ǃ phenotype (Ruth et al., 1997). IS: The inhibitory sequence is 
schematically drawn. It determines the high affinity PKG1ǂ and the low affinity PKG1ǃ phenotype 
(Ruth et al., 1997). cGMP-A binding pocket: cGMP binds in a syn conformation to CNBD-A (see 3.). The 
essential amino acids (T193, L187’, N189’) for cGMP-binding are shown. 
Fig. 1. Structural requirements for interaction of PKG1ǂ and PKG1ǃ with their substrates 
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Table 1. Identification of PKG1 interaction with substrates. 
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The table gives an overview of substrates interacting with PKG1ǂ, PKG1ǃ or both PKG1 
isoforms, their molecular weights, the methods for identification of interaction and their 
main function. 
PKG1 exhibits various functions e.g. in the cardiovascular system, in the lung, in the 
intestine, in platelets and in the central nervous system. PKG1 is important for the relaxation 
of vascular and gastrointestinal smooth muscle. This enzyme inhibits platelet activation and 
thereby protects against arterial thrombosis. Furthermore, in the central nervous system 
PKG1 is involved in processes of learning and memory (Hofmann et al., 2009). In some 
tissues - e.g. smooth muscles - both PKG1 isoforms are expressed. However, there are 
tissues where only the ǂ-isoform is present e.g. in the lung or in the cerebellum, whereas in 
other cells exclusively the ǃ-isoform is found e.g. in the human platelets or in the 
hippocampus. These different locations lead to the view that both isoforms exhibit different 
functions in tissues and cells. Therefore, the identification of isoform-specific substrates was 
a breakthrough to dissect the individual functions of the PKG1ǂ and PKG1ǃ. Particularly, 
regarding smooth muscle contractility the identification of substrates of PKG1ǂ (regulator of 
G-protein signalling 2 (RGS2) and myosin phosphatase subunit 1 (MYPT1)) and of PKG1ǃ 
(inositol trisphosphate receptor-associated cGMP kinase substrate protein (IRAG)) 
substantiated a detailed view of functional regulation by these PKG1 isoforms. RGS2 
phosphorylation regulates the intracellular activity of Gq/11 and thereby reduces the 
intracellular synthesis of InsP3 by phospholipase C. MYPT1 phosphorylation leads to 
calcium desensitization of the cytoskeletal contractility (Schlossmann & Desch, 2009). 
Phosphorylation of IRAG inhibits the intracellular calcium release via InsP3R1. Furthermore, 
IRAG is an important substrate for the NO/cGMP-dependent inhibition of platelet function 
and thereby prevents arterial thrombosis (Hofmann et al., 2006; Schlossmann & Desch, 
2011). Various other substrates were identified in tissues and cells which lead to more 
precise understanding of physiological PKG functions (Hofmann et al., 2009; Schlossmann & 
Desch, 2009). Particularly, the identification of different PKG1-complexes together with its 
substrates directed to specific signalling pathways of the PKG1 isoforms. The elucidation of 
these complexes by affinity chromatography will be reviewed below in part 3 (PKG 
complexes by affinity chromatography). 
3. PKG-complexes by affinity chromatography 
3.1 Immunoprecipitation methods 
Immunoprecipitation utilizes binding of a protein from a tissue or cell lysate to the 
respective primary protein-specific antibody which is linked to a Sepharose matrix followed 
by precipitation of the protein-antibody complex e.g. by centrifugation. If there are 
interacting proteins that build a stable complex with the antibody-bound protein, they can 
also be detected in the precipitate and hence are so called co-immunoprecipitated. The 
matrices used most commonly for co-immunoprecipitation experiments are protein A-
Sepharose or protein G-Sepharose. Protein A and protein G are cell surface proteins from 
staphylococcus aureus or from streptococcus, respectively, which are able to efficiently bind 
immunoglobulins. Protein G-Sepharose binds goat, sheep and mouse primary antibodies 
with higher affinity than protein A-Sepharose (Kaboord & Perr, 2008). 
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For the PKG1, there are different protein complexes, which were identified by co-
immunoprecipitation techniques. An identified PKG complex is the trimeric macrocomplex 
consisting of the PKG1ǃ, IRAG and the InsP3R1 (Fig. 2, Table 1). The previously unknown 
protein IRAG was detected as a PKG1 substrate that could be phosphorylated in the 
presence of cGMP in bovine tracheal smooth muscle membranes. The multimeric complex 
was identified by co-immunoprecipitation experiments with the specific antibodies against 
the three proteins (Schlossmann et al., 2000). In each co-immunoprecipitation test, all three 
components of the complex could be detected in the precipitate. Later, Masuda et al. 
investigated the interaction between all InsP3R-subtypes and IRAG-GFP proteins by co-
immunoprecipitation experiments with anti-GFP antibody (Masuda et al., 2010). Both the 
neuronal S2+-InsP3R1 and the peripheral S2--InsP3R1 interacted with IRAG(GFP) after 
transient expression in COS7 cells. By expressing IRAG∆E12(GFP) which lacked the coiled-
coil interaction site with the InsP3R, the InsP3R1 could not be detected in the 
immunoprecipitation pellet. In contrast, the PKG1ǃ was precipitated with IRAG and with 
IRAG∆E12. In conclusion, there was a stable interaction between PKG1ǃ and IRAG but not 
between PKG1ǃ and the InsP3R1. Additionally, it was shown, that InsP3R2 and InsP3R3 also 
interact with full-length IRAG but not with IRAG∆E12 in COS7 cells (Masuda et al., 2010).  
After that, in an immunoprecipitation experiment with anti-PKG1 antibody phospholamban 
(PLB) was identified as an additional component of the above described signalling complex 
(Koller et al., 2003) (Fig. 2, Table 1). Upon co-expression of InsP3R1, IRAGa, PKG1ǃ and PLB 
in COS7 cells, InsP3R1 and PKG1ǃ could be precipitated with anti-PLB antibody. Moreover, 
solubilized bovine tracheal smooth muscle membranes were incubated with antibodies 
against IRAG, PLB and PKG1 and in each precipitate the trimeric complex could be 
detected. Thus it was demonstrated that PLB is part of the IRAG/PKG1ǃ/InsP3R1 signalling 
complex. 
In 2008, the PDE5 could be verified as a further component of the macrocomplex in human 
platelets (Wilson et al., 2008) (Fig. 2, Table 1). Incubation of platelet lysates with the antisera 
against PDE5, PKG and InsP3R1 allowed co-immunoprecipitation of all three proteins. IRAG 
was not directly detected in the complex because a primary anti-IRAG antibody was not 
available. However, Wilson et al. suggested that IRAG was also a component of this PDE5 
signalling complex, because after 32P-incorporation into the anti-PKG immunoprecipitate a 
band corresponding to the molecular weight of IRAG was detected in the autoradiogram. 
Furthermore, it was shown that only the PKG-associated form of PDE5 could be 
phosphorylated and activated after 8-Br-cGMP treatment and also only the InsP3R1-
associated PDE5 could be selectively activated by PKG1. This was demonstrated by 
measurements of PDE activities in different cellular fractions which contained or were 
devoid of InsP3R1.  
Additionally to the trimeric complex, the interaction between MYPT1 -the myosin-binding 
subunit (MBS) of myosin phosphatase- and PKG1ǂ could be verified by 
immunoprecipitation experiments (Fig. 2, Table 1). Lysates from saphenous vein smooth 
muscle cells were incubated with anti-PKG1ǂ and anti-MYPT1 antibodies and in the first 
case MYPT1 and in the second case PKG1ǂ was detected in the protein A-Sepharose 
precipitate (Surks et al., 1999). Furthermore, in the PKG1ǂ-immunoprecipitate, PP1 
phosphatase activity was measured and also inhibited by the phosphatase inhibitor ocadaic 
acid. After that, to detect possible further PKG1ǂ substrates in the PKG1ǂ-PP1M complex, 
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cGMP and PKG1ǂ were added to anti-MYPT1 immunopellets. In the presence of [Ǆ-32P]ATP 
there was a significantly increased phosphorylation of MYPT1. In 2003, it was hypothesized 
that the leucine zipper domains of MYPT1 and PKG1ǂ mediate the interaction between the 
two proteins (Surks & Mendelsohn, 2003). To further investigate the relevance of the MYPT1 
leucine zipper for the interaction, co-immunoprecipitation experiments were performed 
with chicken smooth muscle cells and chicken smooth muscle tissue (Huang et al., 2004). 
Aorta from embryonic day 15 expressed a leucine zipper positive MYPT1 (LZ+) and gizzard 
smooth muscle tissue from day 7 expressed a LZ- MYPT1 isoform. Both LZ+ and LZ- MYPT1 
isoforms associated with PKG1 and the presence of cGMP increased the binding of the 
MYPT1 to PKG1 in the embryonic aorta. In contrast, in cultured smooth muscle cells, neither 
LZ+ nor LZ- MYPT1 isoforms co-immunoprecipitated with PKG1ǂ. These results suggested 
that the binding of MYPT1 to PKG1ǂ is not mediated by a LZ-LZ interaction. Because 
PKG1ǂ prefers binding to RR and RK motifs (Dostmann et al., 2000) and there is an RK 
motif in the aa 888–928 sequence of MYPT1, the relevance of this sequence was investigated 
(Given et al., 2007). Mutants were generated, which lack or contain this sequence and which 
also lack or contain the leucine zipper. These four MYPT1 mutant proteins were added to 
adult chicken gizzard lysate and chicken aorta lysate and co-immunoprecipitation 
experiments with anti-PKG1ǂ antibody were performed. Only the fragments that contained 
the amino acids 888-928 interacted with PKG1ǂ and the interaction was independent of the 
expression of the leucine zipper (Given et al., 2007). The RK motif within the aa 888-928 
sequence is located at aa 916 and 917, that were mutated to alanine (MYPT1A) or glutamic 
acid (MYPT1E) to investigate whether these two amino acids are important for binding of 
PKG1ǂ. It was shown that MYPT1A binds to PKG1ǂ whereas the interaction between 
MYPT1E and PKG1ǂ is abolished. Therefore the amino acids R916 K917 are important for the 
binding of PKG1ǂ and the interaction depends on the charge of the amino acid residues and 
not on the size. At last, it was proved that an accessory protein may be necessary for 
interaction, because there is a loss of the MYPT1-PKG1ǂ interaction if partially purified 
PKG1ǂ is used in the co-immunoprecipitation experiment with the MYPT1 fragment (Given 
et al., 2007). 
Additionally to the IRAG- and the MYPT1- PKG1 complexes, an interaction between PKG1ǂ 
and the regulator of G-protein signalling-2 (RGS2) was demonstrated (Fig. 2, Table 1). When 
recombinant [35S] RGS2 protein and recombinant PKG1ǂ were combined, a co-
immunoprecipitation of the RGS2 protein with PKG1ǂ was detected (Tang et al., 2003). 
3.2 Affinity chromatography by GST-fusion or His-tagged proteins 
The interaction between two proteins can also be investigated by generation and analysis of 
GST- and His-tagged fusion proteins. A GST-tagged fusion protein contains the glutathione 
S-transferase enzyme and can be purified with glutathione beads. A Polyhistidine-tag 
consists of at least five histidine residues and His-tagged fusion proteins bind to Ni2+-
matrices. These methods were used for the analysis of the interaction of substrate proteins 
with PKG1ǂ or PKG1ǃ. The interactions of the different GST- and His-tagged proteins are 
summarized in table 2. 
The interaction between RGS2 and PKG1ǂ was also demonstrated by analysing GST-fusion 
proteins (Tang et al., 2003). A GST-PKG1ǂ (1-59) fusion protein, which contained the PKG1ǂ 
leucine zipper domain, interacted with the [35S] RGS2 protein. The N-terminal region of  
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Fig. 2. PKG1ǂ and PKG1ǃ complexes identified by affinity chromatography methods 
The filled lines indicate confirmed stable interactions between two complex proteins. When 
the respective interaction sites are known they are illustrated in the figure. The broken lines 
indicate putative interactions of complex proteins.  
Complex proteins: PKG1ǂ/ǃ: cGMP-dependent protein kinase 1ǂ/ǃ; IRAG: inositol-
trisphosphate receptor-associated cGMP-kinase substrate protein; InsP3R1/2/3: inositol 
1,4,5-trisphophate receptor subtype 1/2/3; PDE5: phosphodiesterase 5; TFII-1: general 
transcriptional regulator 1; PLB: phospholamban; CRP4: Cystein rich LIM protein 4; 
MYPT1: myosin targeting subunit of myosin phosphatase; RGS2: regulator of G-protein 
signalling 2 
Interaction sites: LZ: leucine zipper; INT: IRAG-interaction site with PKG1ǃ; CC: coiled-coil 
domain 
RGS2 (GST-RGS2-N; residues 1-79) bound endogenous PKG1ǂ from venous and arterial 
VSMC lysates. In contrast, the GST-RGS2 fusion protein of the C-terminus (GST-RGS2-C 
(80-211)) did not interact with the cGMP-dependent protein kinase. Summing up, the N-
terminus of RGS2 binds the N-terminal leucine zipper domain of PKG1ǂ in vascular smooth 
muscle cells (Fig. 2).  
GST-fusion proteins were also generated to investigate the MYPT1-PKG1ǂ interaction 
(Surks et al., 1999). A GST-MYPT1 protein (GST MYPT1 (850-1030) WT), a GST-tagged 
protein of the C-terminus of the Myosin-binding subunit interacted with PKG1ǂ. After that, 
it was demonstrated with GST-fusion proteins of the N-termini of PKG1ǂ (GST PKG1ǂ (1-
59)), PKG1ǃ (GST PKG1ǃ (1-92)) and PKG2 (GST PKG2 (1-272)) that only PKG1ǂ interacts 
with MYPT1 (Fig. 2). Subsequently, the relevance of the leucine zipper of MYPT1 for the 
interaction with PKG1ǂ was also investigated with GST-tagged proteins. GST-fusion 
proteins of MYPT1 mutants were generated in which two consecutive leucines were 
mutated to alanine (MYPT1 1007A1014A mutant and MYPT1 1021A1028A mutant). Only 
the wild-type GST-MYPT1 bound endogenous PKG1ǂ from human aortic smooth muscle 
cell lysate, the MYPT1 mutants did not interact with the cGMP-dependent protein  
kinase (Surks & Mendelsohn, 2003). The MYPT1 leucine zipper was also relevant for 
homodimerization because these leucine zipper mutant GST-MYPT1 (GST MYPT1 CT181 
L1021A/L1028A and GST MYPT1 CT181 L1007A/L1014A) did not bind MYPT1 from VSMC 
lysate (Surks & Mendelsohn, 2003). On the other hand the PKG1ǂ leucine/isoleucine zipper  
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Table 2. Interaction of GST- and His-tagged fusion proteins (PKG1ǂ, PKG1ǃ and/or its 
substrate proteins). More details of these interactions are given in chapter 3. 
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was dispensable for formation of PKG dimers, which was shown by analysing the 
interaction between GST-tagged wild type and mutant amino-terminal PKG1ǂ and 
endogenous PKG1ǂ from VSMC lysate (Surks & Mendelsohn, 2003). Lee et al. (Lee et al., 
2007) provided data that supported the importance of both the leucine zipper and the C-
terminal CC domain of MYPT1 for the formation of the PKG1ǂ-MYPT1 complex. Therefore, 
the interaction between the leucine zipper of PKG1ǂ (PKG1ǂ1-59) and the C-terminal CC 
domain of the Myosin Binding Subunit was tested (Sharma et al., 2008). A C-terminal His6-
MYPT1 CT100 (residues 930-1030) protein which was bound to Ni2+-NTA resin precipitated 
GST-PKG1ǂ1–59. In isothermal titration calorimetry studies and NMR experiments the 
importance of the residues 929-970 (MYPT1 CT42) for the interaction with the leucine zipper 
of PKG1ǂ was demonstrated (Sharma et al., 2008). In short, if the leucine-zipper motif of 
MYPT1 is absent, the PKG1ǂ leucine-zipper binds to the coiled coil region and upstream 
segments of MYPT1 (Lee et al., 2007). 
GST-fusion proteins were also generated to further investigate the interaction between 
IRAG and PKG1ǃ. A GST-tagged full-length PKG1ǃ interacted in vivo with a Myc-tagged 
IRAG (full-length IRAG WT) after expression of the proteins in COS7 cells (Casteel et al., 
2005). Full-length PKG1ǂ showed no binding of IRAG. Because both PKG1 isoforms bind 
via salt sensitive ionic interactions, the involvement of charged residues within the leucine 
zipper of PKG1ǃ was tested. Acidic residues in the N-terminal sequence of PKG1ǃ were 
mutated and the GST-tagged mutants were expressed in E.coli. These proteins were 
incubated with the Myc- and His-tagged N-terminal IRAG (His/Myc IRAG (1-415) WT). 
Two mutants of PKG1ǃ (GST PKG1ǃ (1-110) E29K and GST PKGIǃ (1-110) D26K/E31R) 
showed no longer binding to IRAG and therefore it was concluded that acidic residues in 
PKG1ǃ mediate the interaction with IRAG. On the other hand, basic residues in the IRAG 
interaction site (residues 100-132) (Ammendola et al., 2001) are necessary for binding of 
PKG1ǃ. To determine the specific amino acids, pairs of basic residues were mutated to 
alanine and the GST-tagged IRAG mutants were tested for their ability to bind PKG1ǃ in 
vitro. Some of the mutants showed completely disrupted binding (GST IRAG (1-415) 
R120A/R124A and GST IRAG (1-415) R124A/R125A) and others showed decreased binding 
to the cGMP-dependent protein kinase (Casteel et al., 2005). The E29K and D26K/E31R 
PKG1ǃ mutants, which exhibited mutations of the acidic residues that are important for the 
interaction with IRAG, could form stable dimers after expression in COS7 cells. Therefore, 
these residues are not necessary for PKG1ǃ homodimerization.  
The importance of PKG1 homodimerization was demonstrated by the cardiovascular 
deficits exhibited by transgenic mice expressing a dimerization-deficient form of PKG1ǂ 
(Michael et al., 2008). To further understand the molecular details of PKG1 dimerization and 
the association of PKG1 dimers with GKAPs, Casteel et al. solved a crystal structure of the 
PKG1ǃ dimerization/docking domain by investigating a His-tagged PKG1ǃ D/D domain 
(Casteel et al., 2011) (described in 2.).  
Similarly to the IRAG-PKG1ǃ interaction, the interaction between PKG1ǃ and the general 
transcriptional regulator TFII-I was investigated (Casteel et al., 2005). Like IRAG, Myc-
tagged TFII-I was only bound by GST-tagged PKG1ǃ but not by PKG1ǂ. It was shown that 
electrostatic interactions are important for binding of PKG1ǃ to GST-TFII-I, because high NaCl 
concentrations (400 mM) disrupted binding. Acidic residues in the PKG1ǃ leucine zipper are 
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important for the interaction with basic amino acids of TFII-I which was proved by analysis of 
GST-tagged PKG1ǃ and TFII-I mutants (Casteel et al., 2005). TFII-I is not only bound but also 
phosphorylated by PKG1 and as a consequence of this transcriptional activation of a serum 
response factor-dependent reporter gene is enhanced (Casteel et al., 2002). 
Fusion proteins were also generated to analyze the interaction between the cysteine-rich 
LIM-only protein CRP4 and PKG1 in vascular smooth muscle cells (Zhang et al., 2007). After 
immunoprecipitation of endogenous CRP4 from PAC1 cells PKG1 was detected in the 
precipitate and Myc-epitope-tagged CRP4 interacted with PKG1ǂ and PKG1ǃ after 
expression in CV1 cells. Additionally, it was shown that cGMP/PKG1 mediated 
phosphorylation of CRP4 had no effect on CRP4-PKG1 association and that Ser104 is the 
major PKG phosporylation site. 
3.3 Cyclic nucleotide affinity methods 
As cGMP-dependent protein kinases are activated by cyclic GMP and contain cGMP 
binding domains they can be purified or bound by cGMP-agarose beads. The 
PKG1ǃ/IRAG/InsP3R1 macrocomplex was not only identified by co-immunoprecipitation 
experiments with the respective primary antibodies but also after expression of the three 
proteins in COS7 cells and then incubating the cell lysate with 8-AET-cGMP-agarose beads 
(Ammendola et al., 2001). The cGMP-agarose affinity method was also performed with 
colon smooth muscle tissues from IRAG-deficient and WT mice (Desch et al., 2010). Thereby 
it was demonstrated that the interaction of PKG1ǃ and InsP3R1 is destroyed by IRAG 
deletion and that the InsP3R1 misses a stable interaction site for PKG1ǃ.  
In 2003, Phospholamban (PLB) was identified as a component of the PKG1ǃ/IRAG/InsP3R1 
signalling complex after bovine tracheal microsomal membrane proteins were purified by 
cGMP–agarose, phosphorylated by 8-pCPT-cGMP and separated by SDS–PAGE or Tricin-
SDS-PAGE (Koller et al., 2003). Beside InsP3R1, IRAG and PKG1ǃ, Phospholamban and 
RhoA were phosphorylated in the presence of cGMP. Smooth muscle ǂ-actin and smooth 
muscle calponin were also present in the cGMP-agarose complex and were identified by 
MALDI-TOF. Additionally, after pre-purification by cGMP-agarose and phosphorylation in 
presence of 8-pCPT-cGMP the microsomal membrane proteins were immunoprecipitated 
with anti-InsP3R1, anti-IRAG, anti-PKG1 and anti-PLB antibody. In each case, the 
autoradiogram showed phosphorylated InsP3R1, IRAG and PKG1ǃ which is a further 
indication that PLB is a component of the macrocomplex and interacts with PKG1ǃ.  
Furthermore, PDE5 is present in the cGMP-agarose complex (Wilson et al., 2008) and an 
increased PDE activity was measured in the cGMP-agarose pellet after 8-Br-cGMP treatment.  
Margarucci et al. investigated the rapid spatial responses of cAMP and cGMP signalling 
complexes induced by collagen stimulation of human platelets (Margarucci et al., 2011). The 
platelets were isolated from whole blood, activated by collagen related peptide (CRP) for 5 
minutes and after platelet lysis the proteins were bound to a 1:1 mixture of 2-AHA-cGMP- 
and 8-AET-cGMP-agarose beads. After that, the proteins were eluted, digested and 
identified and quantified by LC-MS/MS. PKG1ǃ, PKG2, PDE2A and PDE5A were identified 
as primary and IRAG, InsP3R1 and InsP3R2 as secondary interactors. After CRP stimulation, 
the secondary interactors showed increased enrichment versus control whereas binding of 
PKG1ǃ was unaltered and the amount of PKG2 slightly decreased. Moreover, different 
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phosphopeptides were identified and also quantified and it was shown, that phosphorylation 
of IRAG at Ser670 is reduced by 60% after incubation with collagen. Additionally, the 
autophosphorylation of PKG1ǃ at Ser63 was reduced which presumably corresponded to a 
reduced kinase activity and lead to increased platelet activation after CRP stimulation.  
4. Function of PKG complexes 
4.1 IRAG-PKGIβ and the ternary PKG macrocomplex 
IRAG is a 125 kDa substrate of PKG1ǃ which is located at the endoplasmic reticulum 
membrane anchored by a C-terminal tail. IRAG is expressed in high amounts in smooth 
muscle tissues including the vasculature, the gastrointestinal tract and the lung. 
Furthermore, IRAG is found in high concentration in platelets. IRAG expression is also 
found in lower quantity in further tissues including heart, osteoclasts and thalamus. The 
interaction of IRAG was identified by various methods including co-immunoprecipitation, 
cGMP affinity chromatography, two-hybrid analysis and mutagenesis studies. Thereby, an 
N-terminal located 33 aa IRAG domain (aa152-184) was identified which interacts with the 
Ile/Leu-zipper domain of PKG1ǃ but not with PKG1ǂ. Two arginines of the IRAG 
interaction domain (R124 and R125) are essential for the electrostatic interaction with acidic 
aa of PKG1ǃ (D26, E29, E31) (Casteel et al., 2005). PKG1ǃ and IRAG form a ternary complex 
together with InsP3R1 in smooth muscle, platelets and osteoclasts. IRAG is the core 
component of the complex which interacts with the InsP3R1 by its central coiled-coil 
domain. Deletion of this coiled-coil domain prevent the InsP3R1 interaction but does not 
alter IRAG-PKG1ǃ binding. However, the deficiency of IRAG in IRAG-KO mice destructs 
the ternary complex showing that InsP3R1 does not stably interact with PKG1ǃ. The 
function of IRAG in the ternary complex was revealed by targeted deletion of the coiled-coil 
domain or total deletion of IRAG in mice. Thereby, it was elucidated that IRAG is essential 
for NO- and ANP-mediated smooth muscle relaxation (Desch et al., 2010). IRAG deletion 
did not alter basal blood pressure but prevented the blood pressure drop upon LPS-induced 
sepsis (Desch et al., 2010). In platelets, IRAG deletion lead to hyperaggregability and an 
enhanced amount of platelets in the blood. The NO/cGMP-mediated inhibition of platelet 
activation was prevented upon IRAG deletion (Schinner et al., 2011). Concludingly, IRAG 
prevented arterial thrombosis (Antl et al., 2007). Recently, it was reported that IRAG is one of 
seven proteins which exhibited a polymorphism which was associated with enhanced platelet 
aggregability known to be a major factor for the incidence of cardiovascular diseases (Johnson 
et al., 2010). A recent study showed that IRAG might be involved in the activation and 
attachment of osteoclasts (Yaroslavskiy et al., 2010). Furthermore, it was reported that IRAG is 
also able to interact with further InsP3R isoforms, namely InsP3R2 and InsP3R3 (Masuda et al., 
2010). The exact mechanism of IRAG interaction with InsP3R and the inhibition of InsP3R 
gating was not established so far and remains a fundamental subject of IRAG function. 
4.2 MYPT1-PKG1α 
PKG1ǂ interaction with MYPT1, a 130 kDa myosin-binding subunit of phosphatase 1, was 
revealed by co-immunopreciptation, two hybrid analysis and mutagenesis studies. The 
Ile/Leu-zipper domain of PKG1ǂ (aa 1-59) interacts with MYPT1. There are two diverse 
developmentally regulated MYPT1 isoforms existing in vascular smooth muscle: an isoform 
containing a C-terminal leucine zipper (LZ+) which is sufficient to bind to PKG1ǂ and 
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thereby sensitizes cGMP-dependent relaxation. Nitric oxide tolerance was related to 
enhanced degradation of the LZ+-isoform. Moreover, a decreased expression of LZ+ was 
correlated with congestive heart failure. The leucine-zipper deficient isoform (LZ-) 
alternatively interacts with PKG1ǂ through its N1-N2 coiled-coil domain but is cGMP-
insensitive (Payne et al., 2006).  
4.3 RGS2-PKG1α 
The PKG1ǂ-Ile/Leu-Zipper domain interacts with the N-terminal 79aa of RGS2. This RGS2-
domain includes an amphipathic ǂ-helical domain with Ser46 and Ser 64. Upon cGMP-
dependent phosphorylation these Ser residues enable membrane targeting. Vice versa, 
localization of PKG1ǂ at the plasma membrane was enhanced by RGS2 phosphorylation 
suggesting a thereby stabilized complex of these proteins. Thus, RGS2 is activated by 
PKG1ǂ and hence Gq-triggered InsP3-synthesis is attenuated (Tang et al., 2003). Accordingly, 
the deletion of RGS2 in mice impairs cGMP-dependent reduction of calcium transients in 
vascular smooth muscle cells. Furthermore, NO-dependent reduction of blood pressure is 
suppressed in RGS2-deficient mice (Sun et al., 2005). Interestingly, the hypertensive 
phenotype was correlated to nitric oxide function only in inactive phases of mice (during the 
day). In contrast, sympathetic activation and increased vascular adrenergic responsiveness 
correlated with enhanced blood pressure of RGS2-deficient mice in the active phases 
(during the night) (Obst et al., 2006). Recent reports revealed that ANP-signalling is also 
transduced by the PKG1ǂ-RGS2 complex mediating the suppression of angiotensin II-
induced cardiac hypertrophy (Klaiber et al., 2010). 
4.4 Further PKG-substrate complexes 
There are several further proteins which interact with the PKG1 isoforms. However, the 
elucidation of these PKG interacting proteins as PKG substrates was obtained only 
occasionally. The Cystein rich LIM protein CRP4 was identified as PKG1ǂ- and PKG1ǃ-
interacting protein by two hybrid analysis using a smooth muscle cDNA library. CRP4 is 
phosphorylated as substrate by PKG1 (Huber et al., 2000). The CRP4 protein interacts via its 
third zinc finger domain with PKG1 associating together in a complex with serum response 
factor (SRF). Upon cGMP/PKG1 activation CRP4 enhances SRF/DNA association and 
thereby regulates the expression of smooth muscle-specific genes (Zhang et al., 2007).  
A further PKG1ǃ interacting protein is the general transcriptional regulator TFII-1 which 
resides as interface a R4 helix-loop-helix motif (aa 491-628). TFII-1 interacts with basic aa to 
the Leu/Ile domain of PKG1ǃ similarly as reported for the IRAG protein. The TFII-1 
interaction is cGMP-independent. TFII-1 transactivation of a serum-response element was 
enhanced by PKG1ǃ (Casteel et al., 2005).  
5. Conclusion 
The identification of PKG-interacting proteins by affinity chromatographic methods clarified 
several new signalling pathways of PKG1. Furthermore, the dissection of PKG1 isoform 
specific functions of PKG1ǂ and PKG1ǃ was substantiated by the identification of specific 
substrate proteins in several tissues e.g. in smooth muscle, in platelets and in osteoclasts as 
shown above. The advanced elucidation of the function of the known PKG-interacting and 
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substrate proteins will be a cue for the determination of pathophysiological consequences in 
cardiovascular, haematological and gastrointestinal diseases. Furthermore, the diverse 
signal transduction pathways of PKG1 isoforms and the detailed molecular analysis of their 
interactions and possible interferences will lead to new therapeutic horizons. However, the 
ubiquitous expression of PKG1 and the pleiotropic functions of the PKG1 isoforms require a 
very subtle intracellular signal regulation by probably a variety of further substrate proteins 
which were not elucidated so far. Particularly, in immunogical functions, in the renal system 
and in the central nervous system there are a variety of mechanisms which are not explained 
by the current knowledge about PKG signal transduction. The use of interaction assays 
including affinity chromatography methods is tempting to find new pathways which will 
aid in the identification of new (patho)physiological aspects of PKG signalling. 
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